Mark A. Bobko

516 total citations
16 papers, 344 citations indexed

About

Mark A. Bobko is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Mark A. Bobko has authored 16 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Organic Chemistry and 2 papers in Infectious Diseases. Recurrent topics in Mark A. Bobko's work include Chemical Synthesis and Analysis (6 papers), Synthesis and biological activity (2 papers) and Computational Drug Discovery Methods (2 papers). Mark A. Bobko is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Synthesis and biological activity (2 papers) and Computational Drug Discovery Methods (2 papers). Mark A. Bobko collaborates with scholars based in United States, Germany and Japan. Mark A. Bobko's co-authors include Roger A. Smith, Wendy Lee, Karen A. Evans, Timothy B. Lowinger, Jill Kingery-Wood, Jeffrey S. Johnson, Dai‐Shi Su, Arun C. Kaura, Raymond Cooper and Roland E. Dolle and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Mark A. Bobko

16 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Bobko United States 11 197 194 45 35 26 16 344
Shin Iimura Japan 15 302 1.5× 262 1.4× 95 2.1× 47 1.3× 22 0.8× 26 540
Philip N. Collier United Kingdom 11 276 1.4× 213 1.1× 46 1.0× 27 0.8× 14 0.5× 16 401
Fumiyuki Shirai Japan 11 132 0.7× 202 1.0× 49 1.1× 43 1.2× 18 0.7× 27 344
Anthony S. Prokopowicz United States 9 195 1.0× 174 0.9× 57 1.3× 14 0.4× 40 1.5× 10 352
Stephen C. Yabut United States 10 205 1.0× 210 1.1× 37 0.8× 20 0.6× 23 0.9× 14 417
Seyed–Omar Zaraei Egypt 14 210 1.1× 201 1.0× 70 1.6× 31 0.9× 37 1.4× 36 385
Jefferson R. McCowan United States 10 162 0.8× 262 1.4× 94 2.1× 24 0.7× 22 0.8× 19 454
Stephen M. Courtney United Kingdom 12 215 1.1× 346 1.8× 95 2.1× 28 0.8× 34 1.3× 15 572
Steffen Breitfelder Germany 6 179 0.9× 226 1.2× 52 1.2× 17 0.5× 41 1.6× 6 383
Vicki Zhou United States 6 92 0.5× 172 0.9× 42 0.9× 19 0.5× 46 1.8× 6 274

Countries citing papers authored by Mark A. Bobko

Since Specialization
Citations

This map shows the geographic impact of Mark A. Bobko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Bobko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Bobko more than expected).

Fields of papers citing papers by Mark A. Bobko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Bobko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Bobko. The network helps show where Mark A. Bobko may publish in the future.

Co-authorship network of co-authors of Mark A. Bobko

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Bobko. A scholar is included among the top collaborators of Mark A. Bobko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Bobko. Mark A. Bobko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bobko, Mark A., B. Narasimhulu Naidu, Christopher A. Reiher, et al.. (2023). Expeditious Synthesis of a Potent Allosteric HIV-1 Integrase Inhibitor GSK3839919A. Organic Process Research & Development. 27(1). 217–226. 4 indexed citations
2.
Axten, Jeffrey M., Jesús R. Medina, Charles W. Blackledge, et al.. (2012). Acylprolinamides: A new class of peptide deformylase inhibitors with in vivo antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 22(12). 4028–4032. 5 indexed citations
3.
Bobko, Mark A., Arun C. Kaura, Karen A. Evans, & Dai‐Shi Su. (2012). Novel Synthesis of 5-Amino-3-bromo-1-(tert-butyl)-1H-pyrazole-4-carbonitrile: A Versatile Intermediate for the Preparation of 5-Amino-3-aryl-1-(tert-butyl)-1H-pyrazole-4-carboxamides. Organic Letters. 14(15). 3906–3908. 12 indexed citations
4.
Bobko, Mark A., Karen A. Evans, Arun C. Kaura, Leanna E. Shuster, & Dai‐Shi Su. (2011). Synthesis of 2,5-disubstituted-3-cyanoindoles. Tetrahedron Letters. 53(2). 200–202. 15 indexed citations
5.
Grant, Seth W., Timothy F. Gallagher, Mark A. Bobko, Céline Duquenne, & Jeffrey M. Axten. (2011). Rapid synthesis of diversely functionalized 3,4,7-trisubstituted indoles. Tetrahedron Letters. 52(26). 3376–3378. 6 indexed citations
6.
Cywin, Charles L., Baoping Zhao, Daniel W. McNeil, et al.. (2003). Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK). Bioorganic & Medicinal Chemistry Letters. 13(8). 1415–1418. 40 indexed citations
7.
Condon, Stephen M., Christopher J. Burns, Mark A. Bobko, et al.. (2002). Analogues of Human Parathyroid Hormone (1–31)NH2: Further Evaluation of the Effect of Conformational Constraint on Biological Activity. Bioorganic & Medicinal Chemistry. 10(3). 731–736. 1 indexed citations
8.
Smith, Roger A., Donald L. Hertzog, Martin H. Osterhout, et al.. (2002). Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis. Bioorganic & Medicinal Chemistry Letters. 12(9). 1303–1306. 13 indexed citations
9.
Smith, Roger A., J A Barbosa, Mark A. Bobko, et al.. (2001). Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach. Bioorganic & Medicinal Chemistry Letters. 11(20). 2775–2778. 70 indexed citations
10.
Dumas, Jacques, Robert Sibley, Bernd Riedl, et al.. (2000). Discovery of a new class of p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(18). 2047–2050. 34 indexed citations
11.
Smith, Roger A., Mark A. Bobko, & Wendy Lee. (1998). Solid-phase synthesis of a library of piperazinediones and diazepinediones via kaiser oxime resin. Bioorganic & Medicinal Chemistry Letters. 8(17). 2369–2374. 39 indexed citations
12.
13.
14.
Dolle, Roland E., Joseph A. Dunn, Mark A. Bobko, et al.. (1994). 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase. Journal of Medicinal Chemistry. 37(17). 2627–2629. 36 indexed citations
15.
Sawutz, David G., Joseph M. Salvino, Peter R. Seoane, et al.. (1994). Synthesis, Characterization, and Conformational Analysis of the D/L-Tic7 Stereoisomers of Bradykinin Receptor Antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin. Biochemistry. 33(9). 2373–2379. 19 indexed citations
16.
Alvarez, Maria E., David R. Houck, James E. Brownell, et al.. (1994). Isolation and structure elucidation of two new calpain inhibitors from Streptomyces griseus.. The Journal of Antibiotics. 47(11). 1195–1201. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin Iimura Breakdown of academic impact, for papers by Philip N. Collier Breakdown of academic impact, for papers by Fumiyuki Shirai Breakdown of academic impact, for papers by Anthony S. Prokopowicz Breakdown of academic impact, for papers by Stephen C. Yabut Breakdown of academic impact, for papers by Seyed–Omar Zaraei Breakdown of academic impact, for papers by Jefferson R. McCowan Breakdown of academic impact, for papers by Stephen M. Courtney Breakdown of academic impact, for papers by Steffen Breitfelder Breakdown of academic impact, for papers by Vicki Zhou
Rankless by CCL
2026